Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Nonsteroidal Aromatase Inhibitor (NSAI)
DRUG
2 trials
Sponsors
Eli Lilly and Company
Conditions
Breast Neoplasms
Metastatic Breast Cancer
Neoplasm Metastasis
Phase 4
A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer
Withdrawn
NCT03988114
Eli Lilly and Company
Metastatic Breast Cancer
Start: 2019-09-16
End: 2023-03-23
Updated: 2019-09-06
A Study of Abemaciclib in Indian Women With Advanced Breast Cancer
Completed
NCT04707196
Eli Lilly and Company
Breast Neoplasms, Neoplasm Metastasis
Start: 2021-02-22
End: 2023-01-09
Updated: 2023-11-24